منابع مشابه
Cervical Screening (Cervical Smear Test)
Cervical cancer is the third or fourth most common female malignancy worldwide, causing an approximate 529,828 new cases each year. [1] It occurs much more frequently in developing countries. In the UK it is now the 17th most common female cancer, and accounts for 1% of female deaths from cancer. [2] Age-standardised mortality rate for the UK was 2.2 per 100,000 in 2012 (2.1 in England and Wale...
متن کاملCervical Screening (Cervical Smear Test)
Worldwide cervical carcinoma is the second most common female malignancy, causing approximately 500,000 new cases each year. [2] The age-standardised (European) annual incidence rate of cervical cancer is 13.2 per 100,000 females. [2] Age-standardised mortality rate for the UK was 2.9 per 100,000 in 2008. [3] 85-90% are squamous cell cancers and approximately 15% are adenocarcinomas, which are ...
متن کاملThe abnormal cervical smear ALBERT
Squamous cervical cancer (which comprises 95% of all cervical cancers) is completely preventable if its precancerous stages of dysplasia, carcinoma in situ (now called cervical intraepithelial neoplasia), or microinvasive cancer are detected and treated. Detection is relatively simple and entails analysis of a sample of cells exfoliated within the ectocervix and endocervix. Exfoliative cytology...
متن کاملDetection of cervical cancer by irrigation smear and cervical scraping.
Since it was first shown (Papanicolaou and Traut, 1941) that the cytological examination of vaginal secretions could reveal unsuspected gynaecological cancer, various techniques for obtaining suitable cellular preparations have been suggested. Davis (1962) introduced the irrigation smear, using a disposable plastic pipette (cytopipette) containing a cell-preserving fluid. The fluid is ejected i...
متن کاملValue of a negative cervical smear.
Comment Our patient showed a remarkable initial response to high dose intravenous gammaglobulin. The effect on his arthritis was transient, but most of the systemic symptoms were appreciably reduced or absent during the first six months of treatment. A relapse occurred four months after gammaglobulin was stopped, but renewed administration induced the same beneficial effects as before. The mech...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: BMJ
سال: 1994
ISSN: 0959-8138,1468-5833
DOI: 10.1136/bmj.309.6952.476b